Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Screening for atherosclerosis: 2006 update].

Nicolas Rodondi1, Reto Auer, Jacques Cornuz

  • 1Consultation de prévention cardiovasculaire, PMU, Lausanne. Nicolas.Rodondi@hospvd.ch

Revue Medicale Suisse
|February 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased glucocorticoid metabolism in diabetic kidney disease.

PloS one·2022
Same author

Spatial clusters of daily tobacco consumption before and after a smoke-free policy implementation.

Health & place·2021
Same author

[Mass testing for Covid-19 : what can we learn from real-world implementation ?]

Revue medicale suisse·2021
Same author

May direct-to-consumer genetic testing have an impact on general practitioners' daily practice? a cross-sectional study of patients' intentions towards this approach.

BMC family practice·2021
Same author

[To screen or not to screen after age 75 ?]

Revue medicale suisse·2020
Same author

[Principles of prevention and precaution : some guidelines for understanding them].

Revue medicale suisse·2020
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
Same journal

[Integrative medicine : a structured referral framework for general practitioners].

Revue medicale suisse·2026
Same journal

[Targeted therapy for ultra-rare diseases].

Revue medicale suisse·2026
Same journal

[Inherited metabolic diseases in adults : from diagnosis to treatment].

Revue medicale suisse·2026
Same journal

[Cardiogenetics in clinical practice : challenges, indications, and perspectives].

Revue medicale suisse·2026
Same journal

[Genetic medicine illustrated by three key syndromes].

Revue medicale suisse·2026
See all related articles

Screening tests for subclinical atherosclerosis aim to target high-risk patients but require more validation. Their effectiveness in improving outcomes and potential harms like anxiety need further study before widespread clinical use.

Area of Science:

  • Cardiovascular Medicine
  • Preventive Cardiology
  • Diagnostic Testing

Context:

  • Emerging screening tests for subclinical atherosclerosis are being developed.
  • These tests aim to identify individuals at high cardiovascular risk for targeted preventive therapies.
  • Current clinical practice guidelines lack established validation for these novel screening methods.

Purpose:

  • To evaluate the validity and clinical utility of new screening tests for subclinical atherosclerosis.
  • To assess the potential of these tests to improve patient motivation for behavior change (e.g., smoking cessation).
  • To investigate the impact of early atherosclerosis detection and therapy on clinical outcomes and potential harms.

Summary:

  • Several screening tests for subclinical atherosclerosis have emerged, intended to guide preventive treatments for high-risk individuals.

Related Experiment Videos

  • The clinical validity and effectiveness of these tests in improving patient outcomes and motivating behavior change remain poorly understood.
  • Potential harms, such as anxiety induced by screening results, have also not been adequately studied.

    • Impact:

    • Validated screening tests could refine cardiovascular risk stratification and personalize preventive strategies.
    • Further research is needed to confirm the clinical benefits and safety profile before routine implementation.
    • Clinical trials are essential to establish the efficacy and cost-effectiveness of atherosclerosis screening.